Please assess the completion status of the following clinical trial:

Trial Title: Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* ECOG performance status of 0 or 1~* Histological documentation of adenocarcinoma of the colon or rectum. The primary site must have been confirmed to be in the large bowel~Exclusion Criteria:~* Prior systemic anticancer therapy for mCRC~* Prior hepatic surgery, chemoembolization, hepatic artery infusion, radiofrequency ablation or cryotherapy for liver metastases

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).